IRCT20100512003915N21已完成2 期
The efficacy of oral Propranolol in the treatment of the retinopathy of prematurity
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 28 days 至 120 days（—）
- 性别
- All
入选标准
- •Preterm infants with gestational age of less than 30 weeks
- •Birth weight less than 1250 grams
- •Stage 1 or 2 for retinopathy of prematurity
排除标准
- •Infants with congenital anomalies
- •Congenital or acquired cardiovascular disease in neonate
- •Acute renal failure
- •Severe intra-ventricular hemorrhage
研究者
相似试验
招募中
不适用
Clinical study of oral propranolol treatment for infantile hemangiomasinfantile hemangiomasJPRN-UMIN000004604niversity of Tokyo30
已完成
不适用
Clinical study of oral propranolol treatment for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangiomaJPRN-UMIN000004453Gifu University Graduate School of Medicine50
招募中
3 期
Investigating the efficacy of oral propranolol in prevention of severe Retinopathy of PrematurityRetinopathy of prematurityIRCT20101018004961N12Kermanshah University of Medical Sciences50
招募中
1 期
Evaluating the effect of oral Propranolol in preventing the progression of retinopathy of prematurityretinopathy of prematurity.Retinopathy of prematurity, unspecified, bilateralH35.103IRCT20230717058817N1Ardabil University of Medical Sciences66
进行中（未招募）
不适用
Safety and efficacy of treatment with propranolol in newborns suffering from rethinopathy of the preterm: a pilot study - Propranolol and ROPRetinopathy of the pretermMedDRA version: 9.1Level: HLGTClassification code 10047060EUCTR2010-018737-21-ITAZIENDA OSPEDALIERA MEYER